endocrinology-2018-keynote

2 / 8

Journal of Clinical and Molecular Endocrinology
ISSN: 2572-5432
August 09-10, 2018
Madrid, Spain
Endocrinology 2018
Page 16
11th International Conference on
Endocrinology and
Diabetology
T he importance of endocrinology was augmented after the
discovery of the molecular medicine and finding out that all
the vital functions in the body are controlled by the hormones
extra and intra cellular. Many diseases cannot be repaired
without administration of exogenous hormones. The exogenous
hormones take away from the body the privilege of the negative
feedback mechanism which is a mechanism in out body to
control the release of hormones from any gland whenever it
reaches certain level in the blood. This level is different from
one patient to the other, this is the cause for which we read in
the laboratory investigation reports the normal reference has
lower limit and upper limit. Here is the value of the negative feed
back that once the level reaches the needed dose by the body
the negative feed back makes the gland stop releasing more.
Administering exogenous hormone with specific does make
the body use some of this dose and the rest hyper stimulate the
receptors leading to variety of diseases including malignancy.
Using the bio hormonal catalysts help the body to produce the
endogenous hormone and does not take away the privilege of
the negative feed back. Let us discuss together how we can
reach this by using the bio hormonal catalysts and the biological
products.
Biography
Dr. Alaa Abdelkarim, graduated from Cairo University medical school. He
is Founder and Chief Medical Officer of ACE Cells Lab Limited, UK. He isa
Consultant- endocrinology and stem cells therapy. He has more than 28
years of experience and served in more than 8 countries. He received Fel-
lowship of Royal Society of Medicine, Royal Collage of Chemistry, Fellow-
ship of the Malaysian Association of Endocrinology and the International
association for stem cells research. He has been the head of department
of endocrinology and diabetes for more than 8 years treating complica-
tions of diabetes by cellular applications. He has worked in the cell therapy
since 2002 and headed the research department of cell therapy in many
international labs. He is an international Lecturer inmore than 20 countries.
He has registered 20 patents in the field of cell therapy and the protocols
to extract the bioactive materials from live cells either autologous or from
external sources (animal source). He is leading 2 multi-centre clinical trials
in neurodegenerative disease, controlling the complications of diabetes
mellitus type II by cellular applications. He is the Founder of ACE Factor
deficiency theory which is considered as the new trend in regenerating tis-
sues. With many publications and lectures in treating Multiple Sclerosis,
Cerebral palsy and Amyotrophic lateral Sclerosis in different parts of the
world he has supervised many master and PhD researches.
Integration between the bio hormonal
therapy and the biological therapy
to restore our endogenous hormones:
regenerate your endocrine system
Alaa Abdelkarim
ACE Cells Lab Limited, UK
Alaa Abdelkarim, J Clin Mol Endocrinol 2018, Volume 3
DOI: 10.21767/2572-5432-C2-004